Reduction	reduction	O	O	O	O
in	in	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
by	by	O	O	O	O
acetaminophen	acetaminophen	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
patient	patient	O	O	O	O
who	who	O	O	O	O
allegedly	allegedly	O	O	O	O
consumed	consumed	O	O	O	O
100	100	O	O	O	O
tablets	tablets	O	O	O	O
of	of	O	O	O	O
an	an	O	O	O	O
over-the-counter	over-the-counter	O	O	O	O
analgesic	analgesic	O	O	O	O
containing	containing	O	O	O	O
sodium	sodium	CHEMICALS	O	OTHERS	I
acetylsalicylate	acetylsalicylate	O	O	OTHERS	I
,	,	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
acetaminophen	acetaminophen	CHEMICALS	O	OTHERS	I
displayed	displayed	O	O	O	O
no	no	O	O	O	O
significant	significant	O	O	O	O
CNS	cns	O	O	O	O
stimulation	stimulation	O	O	O	O
despite	despite	O	O	O	O
the	the	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
175	175	O	O	O	O
micrograms	micrograms	O	O	O	O
of	of	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
per	per	O	O	O	O
mL	ml	O	O	O	O
of	of	O	O	O	O
serum	serum	O	O	O	O
.	.	O	O	O	O

Because	because	O	O	O	O
salicylates	salicylates	O	O	OTHERS	I
have	have	O	O	O	O
been	been	O	O	O	O
reported	reported	O	O	O	O
to	to	O	O	O	O
augment	augment	O	O	O	O
the	the	O	O	O	O
stimulatory	stimulatory	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
the	the	O	O	O	O
CNS	cns	O	O	O	O
,	,	O	O	O	O
attention	attention	O	O	O	O
was	was	O	O	O	O
focused	focused	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
possibility	possibility	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
acetaminophen	acetaminophen	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
52	52	O	O	O	O
micrograms/mL	micrograms/ml	O	O	O	O
)	)	O	O	O	O
reduced	reduced	O	O	O	O
the	the	O	O	O	O
CNS	cns	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
of	of	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Studies	studies	O	O	O	O
in	in	O	O	O	O
DBA/2J	dba/2j	O	O	O	O
mice	mice	O	O	O	O
showed	showed	O	O	O	O
that	that	O	O	O	O
:	:	O	O	O	O
1	1	O	O	O	O
)	)	O	O	O	O
pretreatment	pretreatment	O	O	O	O
with	with	O	O	O	O
acetaminophen	acetaminophen	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
100	100	O	O	O	O
mg/kg	mg/kg	O	O	O	O
)	)	O	O	O	O
increased	increased	O	O	O	O
the	the	O	O	O	O
interval	interval	O	O	O	O
between	between	O	O	O	O
the	the	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
300	300	O	O	O	O
to	to	O	O	O	O
450	450	O	O	O	O
mg/kg	mg/kg	O	O	O	O
IP	ip	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
onset	onset	O	O	O	O
of	of	O	O	O	O
fatal	fatal	O	O	O	O
convulsions	convulsions	O	DISEASE	OTHERS	I
by	by	O	O	O	O
a	a	O	O	O	O
factor	factor	O	O	O	O
of	of	O	O	O	O
about	about	O	O	O	O
two	two	O	O	O	O
;	;	O	O	O	O
and	and	O	O	O	O
2	2	O	O	O	O
)	)	O	O	O	O
pretreatment	pretreatment	O	O	O	O
with	with	O	O	O	O
acetaminophen	acetaminophen	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
75	75	O	O	O	O
mg/kg	mg/kg	O	O	O	O
)	)	O	O	O	O
reduced	reduced	O	O	O	O
the	the	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
audiogenic	audiogenic	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
produced	produced	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
12.5	12.5	O	O	O	O
to	to	O	O	O	O
75	75	O	O	O	O
mg/kg	mg/kg	O	O	O	O
IP	ip	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
frequency	frequency	O	O	O	O
of	of	O	O	O	O
sound-induced	sound-induced	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
after	after	O	O	O	O
12.5	12.5	O	O	O	O
or	or	O	O	O	O
25	25	O	O	O	O
mg/kg	mg/kg	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
reduced	reduced	O	O	O	O
from	from	O	O	O	O
50	50	O	O	O	O
to	to	O	O	O	O
5	5	O	O	O	O
%	%	O	O	O	O
by	by	O	O	O	O
acetaminophen	acetaminophen	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
absence	absence	O	O	O	O
of	of	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
acetaminophen	acetaminophen	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
up	up	O	O	O	O
to	to	O	O	O	O
300	300	O	O	O	O
mg/kg	mg/kg	O	O	O	O
)	)	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
modify	modify	O	O	O	O
the	the	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
maximal	maximal	O	O	O	O
electroshock	electroshock	O	O	O	O
and	and	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
alter	alter	O	O	O	O
the	the	O	O	O	O
convulsant	convulsant	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
pentylenetetrezol	pentylenetetrezol	O	O	OTHERS	I
in	in	O	O	O	O
mice	mice	O	O	O	O
(	(	O	O	O	O
tests	tests	O	O	O	O
performed	performed	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
Anticonvulsant	anticonvulsant	O	O	O	O
Screening	screening	O	O	O	O
Project	project	O	O	O	O
of	of	O	O	O	O
NINCDS	nincds	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Acetaminophen	acetaminophen	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
up	up	O	O	O	O
to	to	O	O	O	O
150	150	O	O	O	O
micrograms/mL	micrograms/ml	O	O	O	O
)	)	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
retard	retard	O	O	O	O
the	the	O	O	O	O
incorporation	incorporation	O	O	O	O
of	of	O	O	O	O
radioactive	radioactive	O	O	O	O
adenosine	adenosine	CHEMICALS	O	OTHERS	I
into	into	O	O	O	O
ATP	atp	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
slices	slices	O	O	O	O
of	of	O	O	O	O
rat	rat	O	O	O	O
cerebral	cerebral	O	O	O	O
cortex	cortex	O	O	O	O
.	.	O	O	O	O

Thus	thus	O	O	O	O
the	the	O	O	O	O
mechanism	mechanism	O	O	O	O
by	by	O	O	O	O
which	which	O	O	O	O
acetaminophen	acetaminophen	CHEMICALS	O	OTHERS	I
antagonizes	antagonizes	O	O	O	O
the	the	O	O	O	O
actions	actions	O	O	O	O
of	of	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
CNS	cns	O	O	O	O
remains	remains	O	O	O	O
unknown	unknown	O	O	O	O
.	.	O	O	O	O

